CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

Patent ExpiryNeutral
AI Analysis

Summary

CDT notes that Sarborg has filed a substance of matter patent in the cystic fibrosis market.

Outcome Details

Substance of matter patent filing

Importance:2/10
Sentiment:
0.00
patentintellectual propertycystic fibrosisSarborg

Read the original article

Published by GlobeNewswire Pharma on May 7, 2026 12:30 PM

Read Original